Valproate and the risk of hyperandrogenism (multiple letters) [1]

Bipolar Disorders

Volumn 3, Issue 1, 2001, Pages 50-

  Gracious, Barbara L ^a   Wisner, Katherine L ^b  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LITHIUM; ORAL CONTRACEPTIVE AGENT; TESTOSTERONE; VALPROIC ACID;

ACNE; ALOPECIA; BODY MASS; CLINICAL FEATURE; DRUG EFFICACY; DRUG MONITORING; DRUG SAFETY; ECHOGRAPHY; EPILEPSY; FEMALE; GYNECOLOGY; HIRSUTISM; HUMAN; HYPERANDROGENISM; LABORATORY DIAGNOSIS; LETTER; MANIC DEPRESSIVE PSYCHOSIS; MENSTRUAL IRREGULARITY; OVARY FOLLICLE; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PSYCHIATRIST; RISK ASSESSMENT; TRANSVAGINAL ECHOGRAPHY; ULTRASOUND;

ANTICONVULSANTS; FEMALE; HUMANS; HYPERANDROGENISM; VALPROIC ACID;

EID: 0035108412     PISSN: 13985647     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-5618.2001.030107.x     Document Type: Letter

References (0)